Concepedia
Statistics
Publications
26
Citations
1K
H-Index
19
Active since
2012
Affiliations
Pfizer (United States)(Current)
Bristol-Myers Squibb (United States)
New York City College of Technology
City University of New York
STATinMED (United States)
Amol D. Dhamane is an author at Pfizer (United States) specializing in medicine, pharmacotherapy, and anticoagulant therapy.
Publications per year
2012–2024
Short-acting β-agonist use and its ability to predict future asthma-related outcomes
Richard H. Stanford, Manan Shah, Anna O. D’Souza et al. · Annals of Allergy Asthma & Immunology · 2012 · 186 citations
Pharmacy, Pharmacology, Pharmacotherapy +9
COPD exacerbation frequency and its association with health care resource utilization and costs
Amol D. Dhamane, Chad Moretz, Yunping Zhou et al. · International Journal of COPD · 2015 · 100 citations · Full text
Pharmacy, Internal Medicine, Pharmacoeconomics +17
Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population
Phil Schwab, Amol D. Dhamane, Sari Hopson et al. · International Journal of COPD · 2017 · 68 citations · Full text
Medicine, Clinical Sciences, Internal Medicine +17
Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
Gregory Y.H. Lip, Allison Keshishian, Yan Zhang et al. · JAMA Network Open · 2021 · 60 citations · Full text
Medicine, Cardiology, Pharmacotherapy +17
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
Steven Deitelzweig, Allison Keshishian, Xiaoyan Li et al. · Journal of the American Geriatrics Society · 2019 · 54 citations · Full text
Pharmacy, Cardiology, Pharmacotherapy +17
1–5 of 26